These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21351662)

  • 1. [Acute heart failure and early development of left ventricular dysfunction in patients with ST segment elevation acute myocardial infarction managed with primary percutaneous coronary intervention].
    Parenica J; Kala P; Jarkovský J; Poloczek M; Toman O; Goldbergová MP; Manousek J; Prymusová K; Kubková L; Tesák M; Elbl L; Cermáková Z; Spinar J
    Vnitr Lek; 2011 Jan; 57(1):43-51. PubMed ID: 21351662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
    Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
    Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction.
    Saia F; Grigioni F; Marzocchi A; Branzi A
    Am Heart J; 2010 Dec; 160(6 Suppl):S16-21. PubMed ID: 21147287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty.
    Szadkowska I; Pawlicki L; Kowalski J; Banach M; Goch JH; Chizyński K
    Kardiol Pol; 2009 Nov; 67(11):1201-6. PubMed ID: 20024847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular remodeling after primary percutaneous coronary intervention.
    Parodi G; Antoniucci D
    Am Heart J; 2010 Dec; 160(6 Suppl):S11-5. PubMed ID: 21147286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of left ventricular dyssynchrony early after non-ST elevation myocardial infarction without congestive heart failure.
    Ng AC; Tran da T; Allman C; Vidaic J; Leung DY
    Eur Heart J; 2010 Feb; 31(3):298-308. PubMed ID: 19933227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
    Stebbins A; Mehta RH; Armstrong PW; Lee KL; Hamm C; Van de Werf F; James S; Toftegaard-Nielsen T; Seabra-Gomes R; White HD; Granger CB;
    Circ Cardiovasc Interv; 2010 Oct; 3(5):414-22. PubMed ID: 20858863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
    Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of Q waves on presentation and ST resolution in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kumar S; Hsieh C; Sivagangabalan G; Chan H; Ryding AD; Narayan A; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2009 Sep; 104(6):780-5. PubMed ID: 19733711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting irreversible left ventricular dysfunction after acute myocardial infarction.
    Frisch DR; Giedrimas E; Mohanavelu S; Shui A; Ho KK; Gibson CM; Josephson ME; Zimetbaum PJ
    Am J Cardiol; 2009 May; 103(9):1206-9. PubMed ID: 19406260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of additional ST segment elevation in patients with no reflow after angioplasty for acute myocardial infarction.
    Carrabba N; Parodi G; Valenti R; Shehu M; Migliorini A; Santoro GM; Antoniucci D
    J Am Soc Echocardiogr; 2007 Mar; 20(3):262-9. PubMed ID: 17336752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Riba AL; Goswami RG; Peacock WF; Pollack CV; Collins SP; Gibler WB; Ohman EM; Peterson ED;
    Am J Cardiol; 2006 Jun; 97(12):1707-12. PubMed ID: 16765118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.